Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells

• Published in: Oncotarget Vol. 7; no. 30; pp. 48093 - 48106
• Main Authors: Barcus, Craig E, Keely, Patricia J, Eliceiri, Kevin W, Schuler, Linda A
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 26-07-2016
• Subjects: Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cell Line, Tumor; Extracellular Matrix - metabolism; Extracellular Matrix - pathology; Female; Focal Adhesions - metabolism; Focal Adhesions - pathology; Humans; Prolactin - metabolism; Research Paper; Signal Transduction; breast cancer; prolactin; tumor progression; desmoplasia; extracellular matrix
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.10137

Estrogen receptor α positive (ERα+) breast cancer accounts for most breast cancer deaths. Both prolactin (PRL) and extracellular matrix (ECM) stiffness/density have been implicated in metastatic progression of this disease. We previously demonstrated that these factors cooperate to fuel processes involved in cancer progression. Culture of ERα+ breast cancer cells in dense/stiff 3D collagen-I matrices shifts the repertoire of PRL signals, and increases crosstalk between PRL and estrogen to promote proliferation and invasion. However, previous work did not distinguish ECM stiffness and collagen density. In order to dissect the ECM features that control PRL signals, we cultured T47D and MCF-7 cells on polyacrylamide hydrogels of varying elastic moduli (stiffness) with varying collagen-I concentrations (ligand density). Increasing stiffness from physiological to pathological significantly augmented PRL-induced phosphorylation of ERK1/2 and the SFK target, FAK-Y925, with only modest effects on pSTAT5. In contrast, higher collagen-I ligand density lowered PRL-induced pSTAT5 with no effect on pERK1/2 or pFAK-Y925. Disrupting focal adhesion signaling decreased PRL signals and PRL/estrogen-induced proliferation more efficiently in stiff, compared to compliant, extracellular environments. These data indicate that matrix stiffness shifts the balance of PRL signals from physiological (JAK2/STAT5) to pathological (FAK/SFK/ERK1/2) by increasing PRL signals through focal adhesions. Together, our studies suggest that PRL signaling to FAK and SFKs may be useful targets in clinical aggressive ERα+ breast carcinomas.